Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.49 USD | -2.81% | -6.61% | +62.49% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 405M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.62
x | P/E ratio 2025 * |
-8.78
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Neurogene Inc.
1 day | -2.81% | ||
1 week | -6.61% | ||
Current month | -8.67% | ||
1 month | +1.03% | ||
3 months | +4.44% | ||
Current year | +62.49% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 31.49 | -2.81% | 40,122 |
24-05-22 | 32.4 | -0.37% | 44,842 |
24-05-21 | 32.52 | -4.38% | 181,911 |
24-05-20 | 34.01 | +2.10% | 96,435 |
24-05-17 | 33.31 | -1.22% | 49,599 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.49% | 405M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- NGNE Stock